Literature DB >> 25433435

IGF-1 attenuates LPS induced pro-inflammatory cytokines expression in buffalo (Bubalus bubalis) granulosa cells.

K Onnureddy1, Suneel Kumar Onteru1, Dheer Singh2.   

Abstract

Interaction between immune and endocrine system is a diverse process influencing cellular function and homeostasis in animals. Negative energy balance (NEB) during postpartum period in dairy animals usually suppresses these systems resulting in reproductive tract infection and infertility. These negative effects could be due to competition among endocrine and immune signaling pathways for common signaling molecules. The present work studied the effect of IGF-1 (50 ng/ml) on LPS (1 μg/ml) mediated pro-inflammatory cytokine expression (IL-1β, TNF-α, IL-6) and aromatase (CYP19A1) genes' expressions as well as proliferation of buffalo granulosa cells. The crosstalk between LPS and IGF-1 was also demonstrated through studying the activities of downstream signaling molecules (ERK1/2, Akt, NF-κB) by western blot and immunostaining. Gene expression analysis showed that IGF-1 significantly reduced the LPS induced expression of IL-1β, TNF-α and IL-6. LPS alone inhibited the CYP19A1 expression. However, co-treatment with IGF-1 reversed the inhibitory effect of LPS on CYP19A1 expression. LPS alone did not affect granulosa cell proliferation, but co-treatment with IGF-1, and IGF-1 alone enhanced the proliferation. Western blot results demonstrated that LPS caused the nuclear translocation of the NF-κB and increased the phosphorylation of ERK1/2 and Akt maximum at 15 min and 60 min, respectively. Nonetheless, co-treatment with IGF-1 delayed LPS induced phosphorylation of ERK1/2 (peak at 120 min), while promoting early Akt phosphorylation (peak at 5 min) with no effect on NF-κB translocation. Overall, IGF-1 delayed and reversed the effects of LPS, suggesting that high IGF-1 levels may combat infection during critical periods like NEB in postpartum dairy animals.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Buffalo; Crosstalk; Granulosa cells; IGF-1; LPS; Signaling

Mesh:

Substances:

Year:  2014        PMID: 25433435     DOI: 10.1016/j.molimm.2014.11.008

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  6 in total

1.  Syk negatively regulates TLR4-mediated IFNβ and IL-10 production and promotes inflammatory responses in dendritic cells.

Authors:  Hui Yin; Huaxin Zhou; Yi Kang; Xiaoju Zhang; Xiaoxian Duan; Ridab Alnabhan; Shuang Liang; David A Scott; Richard J Lamont; Jia Shang; Huizhi Wang
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 2.  Postpartum uterine infection & ovarian dysfunction.

Authors:  Sunita Dahiya; Suman Kumari; Payal Rani; Suneel Kumar Onteru; Dheer Singh
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

3.  Insulin-Like Growth Factor 1 Regulates Acute Inflammatory Lung Injury Mediated by Influenza Virus Infection.

Authors:  Guiping Li; Lijuan Zhou; Can Zhang; Yun Shi; Derong Dong; Miao Bai; Rong Wang; Chuanfu Zhang
Journal:  Front Microbiol       Date:  2019-11-26       Impact factor: 5.640

4.  Role of endoplasmic reticulum stress in lipopolysaccharide-inhibited mouse granulosa cell estradiol production.

Authors:  Lanjie Lei; Junbang Ge; Hui Zhao; Xiangguo Wang; Lei Yang
Journal:  J Reprod Dev       Date:  2019-08-11       Impact factor: 2.214

5.  Composition and richness of the serum microbiome differ by age and link to systemic inflammation.

Authors:  Thomas W Buford; Christy S Carter; William J VanDerPol; Dongquan Chen; Elliot J Lefkowitz; Peter Eipers; Casey D Morrow; Marcas M Bamman
Journal:  Geroscience       Date:  2018-06-05       Impact factor: 7.713

6.  Alveolar Epithelial Cells Promote IGF-1 Production by Alveolar Macrophages Through TGF-β to Suppress Endogenous Inflammatory Signals.

Authors:  Mimi Mu; Peiyu Gao; Qian Yang; Jing He; Fengjiao Wu; Xue Han; Shujun Guo; Zhongqing Qian; Chuanwang Song
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.